Cancer diagnostics News and Research

RSS

Novel 'designer' nanodevice could improve cancer diagnostics, treatment

Cancer diagnostics and treatment options could be drastically improved with the creation of a 'designer' nanodevice being developed by researchers from the UK, Italy, the US and Argentina.

22 Oct 2014

Anti-cancer nanomedicines with smaller sizes exhibit enhanced performance in vivo, show studies

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy.

17 Oct 2014

Virtual ultrasound elastography can improve breast cancer detection

Next to lung cancer, breast cancer is the leading cause of cancer death in women, according to the American Cancer Society.

17 Oct 2014

Colorado University to limit student work hours -- partly to ease health law coverage requirements

The University of Colorado at Boulder is limiting student employee hours to 25 a week during spring and fall semesters in response to Affordable Care Act provisions, and other CU campuses are doing the same. In a newsletter to students, CU-Boulder said the act - which requires employers to provide health insurance to employees working 30 or more hours per week, or pay fines - was the catalyst for the policy change but not the sole reason. "Not only does the policy support degree attainment as the student's primary focus, it will help assist the campus in achieving chancellor (Phil) DiStefano's initiative of increasing the six-year graduation rate," the newsletter said.

16 Oct 2014

AirXpanders' AeroForm expander shows superior outcomes in patients undergoing breast reconstruction

The latest interim data from XPAND, AirXpanders Inc.’s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, continue to show superior outcomes compared to traditional saline expanders including dramatically shorter expansion times, according to updated clinical data results presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons.

15 Oct 2014

Chesapeake Urology offers revolutionary biopsy system for detection, diagnosis of prostate cancer

Chesapeake Urology Associates ("Chesapeake"), continually on the forefront of clinical and technological innovation, offers a state-of-the-art prostate cancer diagnostic, which "fuses" detailed MRI scans with live, real-time ultrasound images of the prostate.

14 Oct 2014

Columbia University's imaging software gets FDA 510k clearance

Columbia University's imaging software that facilitates 3-D lung tumor segmentation, licensed to Varian Medical Systems, has been incorporated into the Smart Segmentation module of Varian's Eclipse treatment planning system and has received FDA 510k clearance.

10 Oct 2014

RNA molecules in tissue, urine samples can detect prostate cancer

Researchers at Sanford-Burnham Medical Research Institute have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients but not in normal healthy individuals.

10 Oct 2014

Gold Crest Care Center joins the cause to raise awareness for breast cancer

Gold Crest Care Center, one of the leading nursing homes in NYC, has joined the cause to raise awareness for breast cancer education, prevention and treatment. The Bronx, N.Y. facility is dedicated to providing top-notch care for all patients while providing educational services to clients and their families.

9 Oct 2014

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.

9 Oct 2014

Lung cancer can be detected much earlier using lab-on-a-chip technology

Scientists have been laboring to detect cancer and a host of other diseases in people using promising new biomarkers called "exosomes." Indeed, Popular Science magazine named exosome-based cancer diagnostics one of the 20 breakthroughs that will shape the world this year. Exosomes could lead to less invasive, earlier detection of cancer, and sharply boost patients' odds of survival.

8 Oct 2014

NanoString, BWH partner to translate genomic biomarker discoveries into clinical cancer diagnostics

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has signed a multi-year, multi-investigator research collaboration with Harvard-affiliated Brigham and Women's Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics.

From NanoString Technologies 7 Oct 2014

Majority of cancer survivors not financially prepared for cancer diagnosis, treatment

The majority (62%) of America's middle-income cancer survivors say they were not financially prepared for cancer diagnosis and treatment, according to a new study released by the Washington National Institute for Wellness Solutions.

30 Sep 2014

Montefiore-Einstein selected to conduct multi-site cancer clinical trials

Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine of Yeshiva University have been awarded a $3.4 million grant from the National Cancer Institute to conduct multi-site cancer clinical trials and research focused on reducing healthcare disparities in cancer care.

29 Sep 2014

Scientists discover mechanism that resists cancer drugs in estrogen-positive breast cancer

Scientists have discovered a previously unknown mechanism by which estrogen prepares cells to divide, grow and, in the case of estrogen-positive breast cancers, resist cancer drugs. The researchers say the work reveals new targets for breast cancer therapy and will help doctors predict which patients need the most aggressive treatment.

29 Sep 2014

Decision analysis techniques can help women sort through breast reconstruction options

Decision analysis techniques can help surgeons and patients evaluate alternatives for breast reconstruction-leading to a "good decision" that reflects the woman's preferences and values, according to an article in the October issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

29 Sep 2014

Chemotherapy, radiotherapy have no negative effect on unborn babies

Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown.

29 Sep 2014

Access to potentially life-extending cancer drugs varies worldwide

Access to potentially life-extending cancer drugs varies significantly in different regions of the world, two new studies show at the ESMO 2014 Congress in Madrid, Spain.

26 Sep 2014

Study: Simple blood test could identify people with hypercalcaemia

High levels of calcium in blood, a condition known as hypercalcaemia, can be used by GPs as an early indication of certain types of cancer, according to a study by researchers from the universities of Bristol and Exeter.

26 Sep 2014

Researchers test novel robotic system to improve prostate cancer biopsies

A novel robotic system that can operate inside the bore of an MRI scanner is currently being tested as part of a biomedical research partnership program at Brigham and Women's Hospital in Boston with the aim of determining if the robot, in conjunction with real-time MRI images, can make prostate cancer biopsies faster, more accurate, less costly, and less discomforting for the patient.

22 Sep 2014

Cancer diagnostics News and Research

Novel 'designer' nanodevice could improve cancer diagnostics, treatment

Anti-cancer nanomedicines with smaller sizes exhibit enhanced performance in vivo, show studies

Virtual ultrasound elastography can improve breast cancer detection

Colorado University to limit student work hours -- partly to ease health law coverage requirements

AirXpanders' AeroForm expander shows superior outcomes in patients undergoing breast reconstruction

Chesapeake Urology offers revolutionary biopsy system for detection, diagnosis of prostate cancer

Columbia University's imaging software gets FDA 510k clearance

RNA molecules in tissue, urine samples can detect prostate cancer

Gold Crest Care Center joins the cause to raise awareness for breast cancer

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

Lung cancer can be detected much earlier using lab-on-a-chip technology

NanoString, BWH partner to translate genomic biomarker discoveries into clinical cancer diagnostics

Majority of cancer survivors not financially prepared for cancer diagnosis, treatment

Montefiore-Einstein selected to conduct multi-site cancer clinical trials

Scientists discover mechanism that resists cancer drugs in estrogen-positive breast cancer

Decision analysis techniques can help women sort through breast reconstruction options

Chemotherapy, radiotherapy have no negative effect on unborn babies

Access to potentially life-extending cancer drugs varies worldwide

Study: Simple blood test could identify people with hypercalcaemia

Researchers test novel robotic system to improve prostate cancer biopsies

eBook: Liquid biopsy in cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News